袖状胃切除术后新发巴雷特食管风险:长期随访研究的系统评价与Meta分析
该系统评价与Meta分析纳入19项研究共2046例患者(女性79%),评估袖状胃切除术后新发巴雷特食管、糜烂性食管炎、胃食管反流症状、质子泵抑制剂使用及食管裂孔疝的合并发生率,并分析预测因素。结果显示术后新发巴雷特食管合并发生率为5.6%(CI 3.5-8.8),糜烂性食管炎、食管裂孔疝、胃食管反流症状和质子泵抑制剂使用的风险比分别为3.37、2.09、3.32和3.65。术后胃食管反流症状与巴雷特食管发生率正相关。
要点
- 袖状胃切除术后新发巴雷特食管合并发生率为5.6%(CI 3.5-8.8)。
- 术后糜烂性食管炎、食管裂孔疝、反流症状及质子泵抑制剂使用风险均升高。
- 术后胃食管反流症状与巴雷特食管发生率正相关,年龄、性别、BMI等无影响。
核心结论
- 袖状胃切除术显著增加新发巴雷特食管风险,并提高糜烂性食管炎、质子泵抑制剂使用及食管裂孔疝发生率。
- 作者建议临床医生应常规筛查袖状胃切除术后患者的巴雷特食管,未来监测间隔应遵循学会指南。
研究设计与样本
- 系统评价与Meta分析,检索2024年4月的文献,纳入报告袖状胃切除术后巴雷特食管、糜烂性食管炎及食管裂孔疝发生率的研究。
- 共纳入19项研究,2046例患者(女性79%),平均年龄42.2岁(标准差11.1),随访时间2至11.4年。
主要发现
- 袖状胃切除术后新发巴雷特食管合并发生率为5.6%(CI 3.5-8.8)。
- 袖状胃切除术后糜烂性食管炎风险比(RR)为3.37,食管裂孔疝RR为2.09,胃食管反流症状RR为3.32,质子泵抑制剂使用RR为3.65。
- 袖状胃切除术后胃食管反流症状对巴雷特食管合并发生率有正向影响,而年龄、性别、体重指数、术后糜烂性食管炎及食管裂孔疝无影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Sleeve gastrectomy (SG) is one of the most commonly performed bariatric procedures worldwide. Gastroesophageal reflux disease (GERD) is a major concern in patients undergoing SG and is a risk factor for Barrett's esophagus (BE). We conducted a systematic review and meta-analysis to assess the incidence of and analyze predictive factors for post-SG BE. METHODS: A comprehensive literature search was conducted in April 2024, for studies reporting on incidence of BE, erosive esophagitis (EE), and hiatal hernia (HH) post-SG. Primary outcomes were post-SG pooled rates of de novo BE, EE, GERD symptoms, proton pump inhibitor use, and HH. Meta-regression analysis was performed to assess if patient and post-SG factors influenced the rates of post-SG BE. RESULTS: Nineteen studies with 2046 patients (79% females) were included. Mean age was 42.2 years (standard deviation, 11.1) and follow-up ranged from 2 to 11.4 years. The pooled rate of de novo BE post-SG was 5.6% (confidence interval, 3.5-8.8). Significantly higher pooled rates of EE (risk ratio [RR], 3.37], HH (RR, 2.09), GER/GERD symptoms (RR, 3.32), and proton pump inhibitor use (RR, 3.65) were found among patients post-SG. GER/GERD symptoms post-SG positively influenced the pooled BE rates, whereas age, sex, body mass index, post-SG EE, and HH did not. CONCLUSIONS: Our analysis shows that SG results in a significantly increased risk of de novo BE and higher rates of EE, proton pump inhibitor use, and HH. Our findings suggest that clinicians should routinely screen patients with SG for BE and future surveillance intervals should be followed as per societal guidelines.
引用
- Chandan S, Khan SR, Deliwala SS, et al. Risk of De Novo Barrett's Esophagus Post Sleeve Gastrectomy: A Systematic Review and Meta-Analysis of Studies With Long-Term Follow-Up. Clin Gastroenterol Hepatol. 2024. PMID: 39059544. doi:10.1016/j.cgh.2024.06.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。